Neurodevelopmental Outcomes in Infants After In Utero Exposure to SARS-CoV-2 or mRNA COVID-19 Vaccine: What Does the Evidence Say?
The long-term effects of prenatal exposure to SARS-CoV-2 and mRNA COVID-19 vaccines have been a subject of great interest. A new prospective cohort study from the COVI-PREG registry has provided essential insights. The study assessed 330 infants at 12 months of age, comparing those exposed in utero to SARS-CoV-2 or the COVID-19 vaccine with unexposed infants. Using the Ages and Stages Questionnaire (ASQ-3) to evaluate neurodevelopmental outcomes across five domains—communication, gross motor, fine motor, problem-solving, and personal-social development—the findings were reassuring.








